中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
11期
28-29
,共2页
瑞舒伐他汀%曲美他嗪%高血压%阵发性心房颤动
瑞舒伐他汀%麯美他嗪%高血壓%陣髮性心房顫動
서서벌타정%곡미타진%고혈압%진발성심방전동
Rosuvastatin%Trimetazidine%Hypertension%Paroxysmal atrial fibrillation
目的:观察瑞舒伐他汀联合曲美他嗪治疗高血压伴阵发性心房颤动的临床疗效.方法:选取本院2008年5月-2011年5月收治的95例高血压伴阵发性心房颤动患者作为研究对象,均给予瑞舒伐他汀联合曲美他嗪治疗,连续治疗6个月后观察治疗效果.结果:(1)治疗6个月后,本组95例患者显效47例,有效34例,无效14例,总有效率为85.3%.(2)本组患者治疗前后心率、左房内径改变均不明显(P>0.05),但收缩压、舒张压较治疗前有明显改善(P<0.05),差异有统计学意义.(3)本组患者未见明显不良反应.结论:瑞舒伐他汀联合曲美他嗪治疗高血压伴阵发性心房颤动可有效降低心房颤动发生率,且安全性高,值得推广应用.
目的:觀察瑞舒伐他汀聯閤麯美他嗪治療高血壓伴陣髮性心房顫動的臨床療效.方法:選取本院2008年5月-2011年5月收治的95例高血壓伴陣髮性心房顫動患者作為研究對象,均給予瑞舒伐他汀聯閤麯美他嗪治療,連續治療6箇月後觀察治療效果.結果:(1)治療6箇月後,本組95例患者顯效47例,有效34例,無效14例,總有效率為85.3%.(2)本組患者治療前後心率、左房內徑改變均不明顯(P>0.05),但收縮壓、舒張壓較治療前有明顯改善(P<0.05),差異有統計學意義.(3)本組患者未見明顯不良反應.結論:瑞舒伐他汀聯閤麯美他嗪治療高血壓伴陣髮性心房顫動可有效降低心房顫動髮生率,且安全性高,值得推廣應用.
목적:관찰서서벌타정연합곡미타진치료고혈압반진발성심방전동적림상료효.방법:선취본원2008년5월-2011년5월수치적95례고혈압반진발성심방전동환자작위연구대상,균급여서서벌타정연합곡미타진치료,련속치료6개월후관찰치료효과.결과:(1)치료6개월후,본조95례환자현효47례,유효34례,무효14례,총유효솔위85.3%.(2)본조환자치료전후심솔、좌방내경개변균불명현(P>0.05),단수축압、서장압교치료전유명현개선(P<0.05),차이유통계학의의.(3)본조환자미견명현불량반응.결론:서서벌타정연합곡미타진치료고혈압반진발성심방전동가유효강저심방전동발생솔,차안전성고,치득추엄응용.
@@@@Objective:To observe the clinical efficacy of Rosuvastatin statins combined with trimetazidine in the treatment of hypertension with paroxysmal atrial fibrillation.Method:Our hospital from May 2008 to May 2011,95 patients were treated hypertension patients with paroxysmal atrial fibrillation as an object of study,were given rosuvastatin statins combined with trimetazidine treatment,continuous treatment for 6 months observed after treatment effect.Result:(1)After 6 months of treatment,the group of 95 patients,47 cases markedly effective in 34 cases,14 cases were ineffective, the total effective rate of 85.3%.(2)Heart rate,left atrial diameter changes in this group of patients before and after treatment was not significantly(P>0.05), but systolic blood pressure,diastolic blood pressure than before treatment(P<0.05),a statistically significant improvement.(3)The group of patients with no significant adverse reactions. Conclusion:Rosuvastatin the Ting joint qumei-treatment of hypertension with paroxysmal atrial fibrillation can effectively reduce the incidence of atrial fibrillation,and high safety,should be widely applied.